特朗普政府严厉打击药品广告, 推动更清晰的风险披露。 Trump administration cracks down on pharmaceutical ads, pushing for clearer risk disclosures.

特朗普政府宣布对药品广告实行更严格的条例,目的是提高透明度,确保风险得到充分披露。 The Trump administration announced stricter regulations on pharmaceutical advertising, aiming to increase transparency and ensure that risks are fully disclosed. 《使美国再次健康委员会》发布了一项战略,呼吁采取120多项举措,遏制误导性直接对消费者的广告。 The Make America Healthy Again Commission released a strategy calling for more than 120 initiatives to curb misleading direct-to-consumer advertising. 美国食品和药物管理局计划审查数字广告,包括社交媒体上的广告, 并向不符合规定的公司发出执法信. The FDA plans to review digital ads, including those on social media, and has sent out enforcement letters to companies with noncompliant promotions. 这一行动面临着制药业的挑战以及潜在的法律斗争。 The move faces challenges from the pharmaceutical industry and potential legal battles.